SCFAs (acetate, propionate, and butyrate) can enhance the expression of GPR43 while downregulating the expression of NLRP3, IL-18, and IL-1β, thereby strengthening the mucosal immune function of the gut and lungs in rats with chronic obstructive pulmonary disease [85]. This evidence concerns the gene IL18 and chronic obstructive pulmonary disease.